Tickers: XTSX:BGA
Tags: #Bioceuticals
Edmonton, Alberta - TheNewswire - (August 7, 2019) - BioNeutra Global Corporation ("BioNeutra" or the "Company") (TSXV:BGA) is pleased to report on the annual general and special meeting of the shareholders (the "Meeting") for the financial year ended December 31, 2018 held on Tuesday, August 6, 2019. At the Meeting, Dr. Jianhua Zhu, Bill Smith, Doug Horner, Jason Theiss, William Wei, Curtis Sparrow and C.H. William (Bill) Cheung were elected to the Company's board of directors.
Dr. Jianhua Zhu, the Chief Executive Officer and Director of BioNeutra says, "The Company has refreshed its Board of Directors with the election of a number of new and well experienced board members. I welcome these new board members and look forward to working with them to further develop and expand the Company."
Mr. Doug Horner, the newly elected Executive Chairman of the Board states; "I am pleased to be a part of BioNeutra, a company that I have watched with interest for a number of years. I am looking forward to working with this exciting new board and executive team to build further growth and prosperity for the shareholders." Mr. Horner is well experienced in international trade and the food ingredients business with a background in the banking and agriculture industries. He has held numerous positions with the Government of Alberta, including Deputy Premier, President of the Treasury Board, Senior Advisor to the Premier on Internal and Federal-Provincial Relations, as well as Ministerial portfolios in Agriculture, Finance, Advanced Education and Technology and Innovation.
BioNeutra also announces that in addition to the appointment of Doug Horner to serve as Executive Chairman of the Board of Directors, the Board has appointed Ms. Monica Barclay Corporate Secretary of the Company.
In addition, the shareholders of the Company approved at the Meeting a resolution appointing RSM Alberta LLP, Chartered Professional Accountants, as the Company's auditors for the ensuing year and a resolution approving a stock option plan in accordance with the policies of the TSX Venture Exchange. In particular, the terms of the stock option plan allow for a maximum of 10% of the issued and outstanding listed common shares of the Company to be reserved for issuance under the stock option plan, provided that no single participant be issued options representing greater than 5% of the number of outstanding common shares in any twelve month period unless BioNeutra has obtained disinterested shareholder approval.
About BioNeutra
BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on VitaFiber(TM) IMOs.
The Company's lead product, VitaFiber(TM), is an advanced functional and health food and beverage ingredient scientifically made from natural agricultural products, is generally regarded as safe (GRAS) by the U.S. Food & Drug Administration, and is European Food Safety Authority and Health Canada approved as a novel food ingredient. VitaFiber(TM) is naturally sweet and lower in calories than regular sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health.
The Company produces VitaFiber(TM) using its patented processes that naturally transform starch molecules from agriculture cereal crops including Non-GMO corn, wheat, barley, potato, or tapioca into the functional health molecules of VitaFiber(TM) IMO. The VitaFiber(TM) manufacturing process is based upon a natural enzymatic conversion of starch molecules without any chemical modification involved, making VitaFiber(TM) a natural food and beverage ingredient. VitaFiber(TM) is also non-GMO, vegan-friendly, gluten-free, Kosher and Halal certified and available as certified organic.
The Company's customers include a mix of small and medium enterprises and a number of high-profile food and beverage manufacturers in Canada, the U.S., Europe, the United Kingdom, and Mexico. VitaFiber(TM) is also available for retail purchase across the globe through Amazon.com and other direct-to-consumer retailers.
Further information about BioNeutra is available on the Company's website at www.bioneutra.ca and the SEDAR website at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information on BioNeutra, please contact:
Dr. Jianhua Zhu
President and Chief Executive Officer
Tel: (780) 466-1481 (Ext. 132)
Email: jianhua.zhu@bioneutra.ca
Forward-Looking Information
This press release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of BioNeutra. Forward-looking information is based on certain key expectations and assumptions made by the management of BioNeutra. Although BioNeutra believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because BioNeutra can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. BioNeutra disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.
Copyright (c) 2019 TheNewswire - All rights reserved.
